JORDAN GRIFFIS: Open Payments
NPI 1518469071 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,313 in 112 payments from 19 companies in 2025. Trend: 2023 $1,918 · 2024 $2,083 · 2025 $3,313
Food & beverage: $2,189Honoraria: $1,080Education: $43
| Company | Payments | Amount |
|---|---|---|
| MDD US Operations, LLC | 13 | $1,205 |
| ABBVIE INC. | 23 | $423 |
| Eisai Inc. | 13 | $400 |
| Amneal Pharmaceuticals LLC | 10 | $202 |
| ACADIA Pharmaceuticals Inc | 8 | $199 |
| Neurocrine BioSciences, Inc. | 7 | $156 |
| Supernus Pharmaceuticals, Inc. | 10 | $123 |
| Lundbeck LLC | 5 | $112 |
| Otsuka America Pharmaceutical, Inc. | 4 | $86 |
| Teva Pharmaceuticals USA, Inc. | 3 | $71 |
Products named: Gocovri, Leqembi, VYALEV, CREXONT, NUPLAZID, INGREZZA, REXULTI, Qelbree.
Industry payments across FL — which companies pay providers there.
